NFE2L2 and vitiligo: Signaling in the Nrf2-Keap-ARE pathway has been shown to be impaired in human vitiligo melanocytes, and re-establishing normal signaling may be a vitiligo treatment strategy (Jian et al., 2014; Lin et al., 2020).